GLP1-based weight-loss medications, such as semaglutide and tirzepatide, have led to impressive weight-loss results in recent years. At the same time, more and more people, as well as doctors, are reporting a lesser-known side effect: a face that appears older, more hollow, or more fatigued. In the media, this is now commonly referred to as Ozempic Face.
TABLE OF CONTENTS
- What exactly is Ozempic Face?
- What research shows about facial volume and rapid weight loss
- Why this happens in the face
- What you can do about it
- How to prevent or minimise it
What exactly is Ozempic Face?
Ozempic Face is not a medical diagnosis, but a term that is now also used in scientific literature to describe a recognisable pattern: accelerated visible facial ageing following rapid and significant weight loss, often associated with GLP1 medication. It involves a loss of facial volume, particularly in the cheeks and temples, causing the skin to become looser and facial lines to appear deeper.
A systematic review published in 2025 mapped the existing literature on this phenomenon and concluded that it is a real and growing area of attention within aesthetic medicine.
What research shows about facial volume and rapid weight loss
An imaging study published in 2025 in Otolaryngology–Head and Neck Surgery found that every approximately 10 kilograms of weight loss was associated with a reduction of roughly 7% in midface volume. This represents a significant change, especially when weight loss occurs within a relatively short period of time.
Did you know that the face contains a relatively high amount of fat tissue that is among the first areas to respond to a rapidly declining energy balance, even before other parts of the body show noticeable changes?
Why this happens in the face
The face contains structural fat in multiple layers, which contributes to a full and youthful appearance. During rapid weight loss, this fat volume decreases, while the skin and underlying tissues have less time to adapt. Researchers are also investigating whether GLP1 medication may have a direct effect on the cells responsible for collagen production, although this mechanism has not yet been fully established.
The result is a combination of volume loss and reduced skin quality, which together can create an older-looking appearance, even in people who have become healthier in terms of their weight.
What you can do about it
Several treatments are now being used specifically to help address these changes:
- Biostimulatory injectables, including PLLA-based fillers, are currently being investigated in clinical studies specifically for facial laxity following GLP1 therapy, as they stimulate the body’s own collagen production rather than simply adding volume.
- Hyaluronic acid fillers can be used to restore volume in areas where it has been most significantly lost, such as the cheeks.
- Polynucleotides support skin quality and resilience, helping to address the loose, thinner skin that often accompanies rapid weight loss.
- Skin-tightening techniques, such as Sofwave, may contribute to a firmer skin surface without invasive surgery.
How to prevent or minimise it
For those considering or already using GLP1 medication, it can be helpful to pay attention to facial changes before and during the treatment process:
- Where possible, opt for a gradual weight-loss approach in consultation with the prescribing doctor, rather than aiming for the fastest possible results.
- Ensure sufficient protein intake to support muscle and skin tissue during weight loss.
- Have skin quality and facial volume assessed early in the process, so any supportive treatments can be planned in a timely manner.
- Always discuss side effects, including facial changes, with your treating doctor.
Key points to remember
- Ozempic Face describes accelerated facial ageing caused by rapid volume loss following GLP1 use.
- Research shows a measurable link between weight loss and reduced facial volume.
- The cause is a combination of fat loss and, potentially, effects on collagen production.
- Targeted treatments, from biostimulatory injectables to polynucleotides, may help soften these effects.
- Early consultation and a gradual approach can reduce the risk of significant facial changes.
Are you using GLP1 medication or considering it, and would you like to know how to support your face throughout this process? During a consultation at POMME Clinics, we will explore together which treatment, if needed, best fits your journey.
